Tag Archives: Nordisk

Ozempic Maker Novo Nordisk to Slash 9,000 Jobs  The Wall Street Journal Wegovy-maker Novo Nordisk to slash 9,000 jobs as competition heats up  Reuters Novo to Cut 11% of Workforce as New CEO Slashes Forecast  Bloomberg.com Novo Nordisk, maker of obesity drug Wegovy, to cut 9,000 jobs to sharpen focus, meet competition  Yahoo Finance Wegovy-maker Novo Nordisk to cut around 9,000 jobs  CNBC Source link

Novo Nordisk Will Cut 9,000 Jobs Globally to Save $1.3 Billion  Bloomberg.com Wegovy-maker Novo Nordisk to cut around 9,000 jobs  CNBC Wegovy-maker Novo Nordisk to slash 9,000 jobs as competition heats up  Reuters Wegovy-maker Novo Nordisk to cut nearly 9,000 jobs (NVO:NYSE)  Seeking Alpha Novo Nordisk to cut 11 per cent of jobs  Financial Times Source link

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images Danish pharmaceutical giant Novo Nordisk on Wednesday announced plans to cut around 9,000 roles, or roughly 11.5% of its global workforce. “Novo Nordisk today announced a company-wide transformation to simplify its organisation, improve the speed of decision-making, and reallocate resources …

Novo Nordisk Says Wegovy Cuts Heart Risk by 57% Compared With Eli Lilly’s Obesity Drug – WSJ  The Wall Street Journal Novo Nordisk’s Wegovy cuts heart risk by 57% versus rival Lilly weight-loss drug in study  Reuters Wegovy trial result gives boost to Novo Nordisk amid U.S. market woes  CNBC Novo’s Wegovy Beats Lilly’s Zepbound for Heart Health, Study Finds. What It Means …

Novo Nordisk (NVO) stock was down on Tuesday, despite a lack of news from the pharmaceutical company. Instead, investors can turn to rival drug maker Eli Lilly (LLY) to learn why shares of NVO stock have fallen today. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights …

Drugmaker Novo Nordisk freezes hiring for non-critical jobs  Reuters Novo Nordisk’s new CEO is said to start hiring freeze to cut costs (NVO:NYSE)  Seeking Alpha Novo Nordisk’s New CEO Starts Hiring Freeze in Cost-Cutting Push  Bloomberg.com Pharmalittle: We’re reading about a Novo hiring freeze, coverage for GLP-1 drugs, and much more  statnews.com Novo Nordisk’s Human Capital Shift: A Calculated Bet on R&D Efficiency and …

GoodRx Announces Collaboration with Novo Nordisk to Expand Access to Ozempic  Business Wire Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients  CNBC GoodRx stock soars after striking deal to sell Novo Nordisk’s GLP-1s for $499/month  Yahoo Finance Novo Nordisk halves US price of Ozempic  Financial Times Novo Nordisk offers Ozempic at $499 per month to eligible …

Novo Nordisk offers Ozempic at $499 per month to eligible US cash-paying customers  Reuters Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients  CNBC GoodRx stock soars after striking deal to sell Novo Nordisk’s GLP-1s for $499/month  Yahoo Finance Novo Nordisk halves US price of Ozempic  Financial Times Novo Halves Ozempic Price to $499 a Month for …

Dayforce, Novo Nordisk, GoodRx, UnitedHealth, Sunrun, TeraWulf, and More Movers  Barron’s Stocks making the biggest moves premarket: Dayforce, Sunrun, Tesla, Novo Nordisk and more  CNBC 5 Things to Know Before the Stock Market Opens  Investopedia Stocks to Watch Monday: Novo Nordisk, TeraWulf, UnitedHealth, Soho House  The Wall Street Journal Top Stock Movers Now: Dayforce, Novo Nordisk, First Solar, and More  Yahoo Finance Source link

Wegovy News Pushes Novo Nordisk Stock Higher  Barron’s Novo Nordisk shares pop after Wegovy receives U.S. approval for liver disease  CNBC Wegovy Gets F.D.A. Approval for MASH  The New York Times Novo’s Wegovy becomes first GLP-1 drug approved for MASH  BioPharma Dive FDA Approves Novo Nordisk’s Wegovy for Liver Disease  The Wall Street Journal Source link